Detection of human papillomavirus in non-small cell carcinoma of the lung.
High-risk human papillomavirus (hrHPV) is an etiologic agent in squamous cell carcinoma (SqCC) arising in the oropharynx and cervix, and a proven prognostic factor in oropharyngeal SqCC. Many studies have found HPV in non-small cell lung carcinoma (NSCLC). Recent studies advocate the detection of messenger RNA transcripts of E6/E7 as more reliable evidence of transcriptively active HPV in tumor cells. The clinical significance of finding HPV remains unclear in NSCLC. This study sought to determine the prevalence of biologically active HPV infection in NSCLC comparing different methodologies. Surgical pathology material from resected primary lung adenocarcinoma (ADC; n=100) and SqCC (n=96) were retrieved to construct tissue microarrays. In situ hybridization (ISH) for hrHPV DNA (DNA-ISH), hrHPV E6/E7 RNA (RNA-ISH), and p16 immunohistochemistry were performed. Cases of oropharyngeal SqCC with known HPV infection were used as positive controls. Expression of p16 was scored as positive if at least 70% of tumor cells showed diffuse and strong nuclear and cytoplasmic staining. Punctate nuclear hybridization signals by DNA-ISH in the malignant cells defined an HPV-positive carcinoma. Of the 196 patients (range, 33-87 years; 108 men), p16 was positive in 19 ADCs and 9 SqCCs, but HPV DNA-ISH and RNA-ISH were negative in all cases. Our study did not detect HPV infection by DNA-ISH or RNA-ISH in any cases of primary NSCLC despite positive p16 expression in a portion of ADC and SqCC. p16 should therefore not be used as a surrogate marker for HPV infection in NSCLC.
Department of Anatomic Pathology, Sunnybrook Health Sciences Centre, Toronto, ON, Canada M4N 3M5. Electronic address: singyun.chang@fraserhealth.ca.
Sing Yun
SY
Chang
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905.
Michael
M
Keeney
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905.
Mark
M
Law
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905.
Janis
J
Donovan
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905.
Marie-Christine
MC
Aubry
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905.
Joaquin
J
Garcia
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002289:Carcinoma, Non-Small-Cell Lung / Q000473:pathology / Q000821:virology*; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000473:pathology / Q000821:virology*; D008297:Male; D008875:Middle Aged; D009959:Oropharyngeal Neoplasms / Q000473:pathology / Q000821:virology*; D027383:Papillomaviridae / Q000302:isolation & purification*; D030361:Papillomavirus Infections / Q000821:virology*; D012189:Retrospective Studies
Human papillomavirus; In situ hybridization; Non–small cell lung carcinoma; RNAscope; p16